Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type
- PMID: 7545390
- DOI: 10.1006/bbrc.1995.2267
Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type
Abstract
CD44 is a major cell-surface receptor for hyaluronate (HA). By alternative RNA-splicing a large number of CD44 variants are generated. To explore the role of CD44 splicing in the regulation of cell binding to HA, three different isoforms of CD44 were transfected in the CD44 negative B-cell lymphoma line Namalwa and in the fibroblastoid cell line COS7. We observed that whereas the standard form of CD44 (CD44s) mediated adhesion of Namalwa to HA, Namalwa transfected with CD44v3-10 or CD44v8-10 was unable to bind to either immobilized or soluble HA. After stimulation of CD44 with an activating anti-CD44 mAb or with phorbol ester, the binding of CD44s to HA was 5- to 10-fold higher than that of the other two isoforms. By contrast, COS7 cells transfected with CD44s, CD44v8-v10, or CD44v3-v10 bound equally effectively to HA. Hence, in addition to alternative splicing, cell type determines CD44 binding to HA.
Similar articles
-
Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.J Cell Biol. 1995 Feb;128(4):673-85. doi: 10.1083/jcb.128.4.673. J Cell Biol. 1995. PMID: 7532175 Free PMC article.
-
Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.J Cell Physiol. 1995 Sep;164(3):605-12. doi: 10.1002/jcp.1041640319. J Cell Physiol. 1995. PMID: 7544357
-
Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.J Biol Chem. 1994 Mar 25;269(12):9074-8. J Biol Chem. 1994. PMID: 7510702
-
CD44: structure, function, and association with the malignant process.Adv Cancer Res. 1997;71:241-319. doi: 10.1016/s0065-230x(08)60101-3. Adv Cancer Res. 1997. PMID: 9111868 Review.
-
Schwann cell tumors express characteristic patterns of CD44 splice variants.J Neurooncol. 1995 Dec;26(3):171-84. doi: 10.1007/BF01052620. J Neurooncol. 1995. PMID: 8750183 Review.
Cited by
-
CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.Oncol Rep. 2021 Apr;45(4):7. doi: 10.3892/or.2021.7958. Epub 2021 Mar 2. Oncol Rep. 2021. PMID: 33649828 Free PMC article.
-
The Labeling, Visualization, and Quantification of Hyaluronan Distribution in Tumor-Bearing Mouse Using PET and MR Imaging.Pharm Res. 2020 Nov 4;37(12):237. doi: 10.1007/s11095-020-02957-y. Pharm Res. 2020. PMID: 33151373
-
Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment.Front Immunol. 2019 May 10;10:947. doi: 10.3389/fimmu.2019.00947. eCollection 2019. Front Immunol. 2019. PMID: 31134064 Free PMC article. Review.
-
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.Front Immunol. 2015 May 6;6:201. doi: 10.3389/fimmu.2015.00201. eCollection 2015. Front Immunol. 2015. PMID: 25999946 Free PMC article. Review.
-
Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity.Arthritis Rheum. 2010 May;62(5):1431-7. doi: 10.1002/art.27385. Arthritis Rheum. 2010. PMID: 20213807 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous